Keywords: amri, drug, discovery, deal, b-ms, albany, molecular

AMRI in drug discovery deal with B-MS

Article | 22 December 2006

Albany Molecular Research Inc has entered into a two-year natural products-based drug discovery collaboration with drug major Bristol-Myers Squibb.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in